A detailed history of Steward Partners Investment Advisory, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 26 shares of CTLT stock, worth $1,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 26 -0.0%
Holding current value
$1,585
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$53.58 - $57.02 $1,446 - $1,539
-27 Reduced 50.94%
26 $1,000
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $1,149 - $1,615
27 Added 103.85%
53 $2,000
Q4 2023

Feb 12, 2024

BUY
$32.18 - $46.57 $547 - $791
17 Added 188.89%
26 $1,000
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $2,272 - $3,713
-50 Reduced 84.75%
9 $0
Q4 2022

Feb 15, 2023

BUY
$41.39 - $81.0 $2,442 - $4,779
59 New
59 $2,000
Q2 2022

Aug 04, 2022

SELL
$87.2 - $114.05 $3,313 - $4,333
-38 Reduced 25.33%
112 $12,000
Q1 2022

May 02, 2022

SELL
$94.19 - $124.49 $4,709 - $6,224
-50 Reduced 25.0%
150 $17,000
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $21,834 - $28,470
200 New
200 $27,000
Q1 2020

Apr 29, 2020

SELL
$36.95 - $62.95 $2,364 - $4,028
-64 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$47.06 - $56.64 $4,847 - $5,833
-103 Reduced 61.68%
64 $3,000
Q2 2019

Jul 25, 2019

BUY
$39.26 - $54.21 $6,556 - $9,053
167 New
167 $9,000
Q4 2018

Jan 15, 2019

SELL
$29.95 - $46.34 $7,367 - $11,399
-246 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$40.12 - $45.55 $9,869 - $11,205
246 New
246 $11,000
Q4 2017

Jan 19, 2018

SELL
$37.27 - $43.02 $2,795 - $3,226
-75 Closed
0 $0
Q2 2017

Nov 22, 2017

BUY
N/A
75
75 $2,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.